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O-glycosylation is a ubiquitous eukaryotic post-translational modiﬁcation, whereas early reports of
S-linked glycopeptides have never been veriﬁed. Prokaryotes also glycosylate proteins, but there are
no conﬁrmed examples of sidechain glycosylation in ribosomal antimicrobial polypeptides collec-
tively known as bacteriocins. Here we show that glycocin F, a bacteriocin secreted by Lactobacillus
plantarum KW30, is modiﬁed by an N-acetylglucosamine b-O-linked to Ser18, and an N-acetylhexos-
amine S-linked to C-terminal Cys43. The O-linked N-acetylglucosamine is essential for bacteriostatic
activity, and the C-terminus is required for full potency (IC50 2 nM). Genomic context analysis iden-
tiﬁed diverse putative glycopeptide bacteriocins in Firmicutes. One of these, the reputed lantibiotic
sublancin, was shown to contain a hexose S-linked to Cys22.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glycosylation is a ubiquitous eukaryotic post-translational
modiﬁcation, the glycans being typically linked to asparagine
(N-linked) or serine/threonine (O-linked) sidechains and fulﬁlling
physicochemical and/or molecular recognition roles [1]. There is
also a growing appreciation of the extent and functional signiﬁ-
cance of bacterial glycoproteomes [2,3].
Prokaryotes secrete bacteriocins, ribosomally synthesised anti-
microbial polypeptides that often have a narrow phylogenetic
range of toxicity determined by speciﬁc interactions with receptor
molecules and/or targets of inhibitory action [4]. Some bacteriocins
exhibit unusual post-translational modiﬁcations [5,6], for example
the C-terminal glycosyl ester linkage in microcin E492m [7], but
there are no conﬁrmed reports of bacteriocins with glycosylated
sidechains.chemical Societies. Published by E
eglycosylated GccF; GccF1–41,
cosamine; HexNAc, N-acetyl-
rier transform ion cyclotron
at decreases growth rate by
acetic acid
).Glycocin F (GccF, formerly plantaricin KW30), secreted by Lacto-
bacillus plantarum KW30, is stable between pH 2-10, and at 100 C
for 2 h, and is unaffected by incubation with a-amylase and lyso-
zyme [8]. These properties, deduced from studies on culture super-
natant, are typical of bacteriocins from L. plantarum [9] and other
lactic acid bacteria.
Here we present the molecular characterisation of puriﬁed GccF
and show that it contains post-translational modiﬁcations not
described previously in bacteriocins, including peptide cysteine
S-glycosylation which is without veriﬁed biological precedent.
Earlier accounts of naturally occurring cysteine (S-linked) glyco-
peptides [10,11] are almost forty-years old and in doubt because
the peptide sequences (GenBank accessions P02728, P02729) have
not been found in the human proteome.
Genomic context analysis indicated the sporadic occurrence of
diverse putative glycopeptide bacteriocins (glycocins) in Firmi-
cutes. We conﬁrmed that one of these, the reputed lantibiotic
sublancin 168 [12], is in fact an S-linked glycopeptide bacteriocin.
These discoveries expand our awareness of the array of post-
translational modiﬁcations available to confer antimicrobial and
other properties on peptide scaffolds, and support the contention
that bacteriocin diversity is greater than is currently recognised
[13].lsevier B.V. All rights reserved.
Fig. 1. (A) Schematic of GccF and sublancin 168, including enzymatic dissection of
GccF. Trypsin cleavage produces GccF1–32 and GccF33–43, N-acetyl-b-D-glucosamin-
idase hydrolyses the O-glycosidic bond yielding deOGlcNAcGccF and deOGlcNAcGccF1–32,
chymotrypsin cleavage yields His42Cys43-HexNAc, and partial chymotrypsin
cleavage yields GccF1–41. (B) CD spectra of GccF and fragments. GccF_RA, reduced
and alkylated GccF.
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2.1. Bacterial strains and culture conditions
L. plantarum strains (KW30, ATCC 8014) were grown at 30 C in
MRS medium (Merck). For GccF production KW30 was grown at
22 C. For sublancin production Bacillus subtilis BR151 (BGSC, Ohio
State University) was grown as described by Paik et al. [12].
2.2. Bacteriocin puriﬁcation
Supernatant from a three-day 8 L KW30 culture was adjusted to
pH 7 with NH4OH and stirred overnight with 1 L phenyl Sepharose
(FF, low substitution, GE Healthcare). The resin was packed into a
glass column, washed with 3 L 2% NH4HCO3 and eluted with 2 L
2% NH4HCO3, 40% ethanol. Fractions (10 ml) containing active GccF
were pooled, concentrated to 12 ml by rotary evaporation, then
puriﬁed by RP-HPLC (Jupiter 5 lm C18 300 Å, 250  10 mm, Phe-
nomenex; 1 ml injection, 5 ml min1, 25 min 0–50% B linear gradi-
ent. A: H2O, 0.1% triﬂuoroacetic acid (TFA); B: acetonitrile, 0.08%
TFA). GccF, eluting at 40% B, was lyophilised (Fig. S1). The yield
of puriﬁed GccF was 0.5–1 mg L1 of culture. Active sublancin
168 was puriﬁed as described by Paik et al. [12].
2.3. Enzymatic dissection
GccF (1 mg ml1 in 1 ml 1% NH4HCO3, pH 8.1) was incubated
with 10 lg trypsin (Promega) overnight at room temperature. The
digest was fractionated by RP-HPLC (Jupiter 5 lm C18 300 Å,
250  4.6 mm, Phenomenex; 1 ml min1, gradient as in Section 2.2)
to purify GccF1–32 and GccF33–43. A chymotryptic digest under simi-
lar conditionswith aGccF:protease ratio of 50:1byweightwas incu-
bated for 4.5 h and fractionated as above to purify peptide fragment
1–41 of GccF (GccF1–41) and ‘HX’ (His42Cys43-N-acetylhexosamine
(HexNAc)). GccF and GccF1–32 (each 1 mg ml1 in 1 ml 50 mM
sodium acetate buffer, pH 4.5, 5 mM EDTA) were O-deglycosylated
by adding 0.5 mg puriﬁed recombinant N-acetyl-b-D-glucosamini-
dase GcnA [14] and incubating overnight at room temperature.
Reaction samples were analysed using MALDI-TOF MS (Micromass
m@ldi) to detect the loss of O-linked HexNAc, and O-deglycosylated
peptides puriﬁed as described for proteolytic fragments.
2.4. Analytical methods
GccF, reduced GccF, reduced and alkylated GccF, O-deglycosy-
lated GccF (deOGlcNAcGccF), GccF1–41, GccF1–32, deOGlcNAcGccF1–32,
GccF33–43, C-terminal peptide His42Cys43-HexNAc and sublancin
were characterised by tandem mass spectrometry (PE SCIEX API
300 LC/MS/MS, PE Sciex Instruments; micrOTOF-Q, Bruker Dalton-
ics; 9.4T APEX-Q Ultra Fourier transform ion cyclotron resonance
mass spectrometry (FT-ICR-MS), Bruker Daltonics). Circular dichro-
ism (CD) spectra were collected on a ChirascanTM spectrometer
(Applied Photophysics, U.K.). Experimental details of MS and CD
spectroscopy, Edman and DNA sequencing, and bioinformatic
methods are given in Supplementary data. Nucleotide sequence
of the gcc cluster (6789 bp) was deposited in GenBank, accession
number GU552553.
2.5. GccF activity assays
MRSmedium containing 1% bacteriological agar was autoclaved
then cooled to 40 C. ATCC 8014 cells were added to 3  106
cells ml1 and 15 ml of this indicator agar was poured immediately
into 7.2 cm diameter Petri dishes. Samples (2.5 ll) were pipetted
onto indicator plates and incubated overnight at 30 C. To detect
antibacterial activity associated with peptides analysed by tricineSDS–PAGE, destained gels were overlaid with indicator agar. For
IC50 determinations, the optical density (O.D. 600 nm) of 3 ml sus-
pensions of 3  107 cells ml1 in MRS medium at 30 C was
monitored (Hitachi U-1100 spectrophotometer) after addition of
GccF and peptide fragments. IC50 is the concentration that halves
the rate of O.D. 600 nm increase excluding the lag phase prior to
inhibition. Tricine SDS–PAGE and LIVE/DEAD cell assay methods
are described in Supplementary data.
3. Results
3.1. Structural characterisation of GccF
The predicted monoisotopic mass of GccF is 4796.9197 Da,
whereas the mass measured by FT-ICR-MS was 5199.0488 Da
(shown as [M+H]+ 5200.0561 Da in Fig. S2). GccF was analysed
by Edman sequencing (Table S1) and FT-ICR-MS with electron cap-
ture dissociation (ECD) (Table S2), and shown to contain two types
of post-translational modiﬁcations that account for the observed
mass difference (Fig. 1A, C226H311N57O72S7, theoretical monoiso-
topic mass 5199.0472 Da). Firstly, Edman sequencing identiﬁed
two nested disulﬁde bonds (Cys5–Cys28 and Cys12–Cys21) – the
same constrained (C–X6–C)2 ‘hairpin architecture’ was reported
for sublancin 168 [12]. Secondly, FT-ICR-MS identiﬁed two
HexNAcs, one linked to Ser18 and the other to Cys43. Partially
glycosylated forms of GccF were not detected. Treatment with
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Ser18-linked HexNAc from GccF and GccF1-32 (Fig. S3), indicating
that this HexNAc moiety is a b-O-linked N-acetylglucosamine
(GlcNAc). Reduction of GccF CNBr peptides generated four free
thiols that reacted with 4-vinyl pyridine (Table S1), whereas native
(disulﬁde-bonded) GccF did not react with 4-vinyl pyridine or
iodoacetamide. Edman sequencing, FT-ICR-MS and chemical
modiﬁcation results all supported the conclusion that GccF con-
tains no free thiols; Cys5, Cys12, Cys21 and Cys28 thiols form
disulﬁde bonds, and the C-terminal HexNAc is S-linked to the
Cys43 thiol. Methyl esteriﬁcation [15] of GccF provided evidence
that the Cys43 HexNAc is not linked via the C-terminal carboxylate,
as Asp17, Asp22 and the C-terminus were esteriﬁed.
CD spectra of GccF were dominated by bands at 193 and
210 nm, characteristic of helical structure, which diminished on
reduction and alkylation (Fig. 1B). Compared to GccF, some of the
decrease in 193 and 210 nm band intensity may be attributed to
the loss of one (deOGlcNAcGccF, GccF1–32) or two (deOGlcNAcGccF1–32)
HexNAcs [16]. However, the magnitude of the differences suggests
that changes in secondary structure occurred when GccF33–43 was
removed, and that further changes occurred when GccF1–32 was O-
deglycosylated (a 230 nm band appeared), despite the disulﬁde
bonds remaining intact throughout (Fig. S3).
3.2. GccF activity
Bacteriocins of lactic acid bacteria are typically cationic bacteri-
cidal peptides that kill by disrupting cell membrane integrity
[4,17,18]. KW30 supernatant is apparently bactericidal to ATCC
8014 [8], and this differs from puriﬁed GccF (pI 7.04) which had
negligible bactericidal activity, e.g. incubation with 200 nM GccF
for 5 h resulted in only 5% cell death (Fig. S4). Rather, puriﬁed GccF
caused rapid and sustained bacteriostasis (IC50 2 nM; Fig. S5A).
GccF activity results are summarised in Fig. 2. deOGlcNAcGccF and
deOGlcNAcGccF1–32 were inactive, showing that the O-linked GlcNAc
is essential for activity. GccF33–43 was also inactive, and did not
increase the residual activity of GccF1–32. Elevated IC50 values
for C-terminal truncations GccF1–41 (130 nM) and GccF1–32
(350 nM) (Fig. S5B and C) showed that the C-terminus, and
His42Cys43-HexNAc in particular, is required for full potency.
Reduced GccF was inactive in indicator agar overlays of tricine
SDS–PAGE gels (Fig. 2B, inset, lane 1).
Free GlcNAc protected cells against bacteriostasis by GccF and
active fragments (Fig. 2A, compare columns 1 and 2). GlcNAc dif-
fusing from samples in the left column decreased activity on theFig. 2. Activity of GccF and fragment peptides. (A) Top three rows: 2.5 lL samples at pe
0.5 M GlcNAc; (ii) 100 lMGccF1–32 + 200 lMGccF33–43; (iii) 200 lMGccF33–43; (iv) 200 l
100 minutes after the addition of 8 nM GccF at 0 min. Inset: SDS–PAGE gels overlaid with
(2) non-reduced GccF; (3) deOGlcNAcGccF1–32 (inactive); (4), GccF1–32 (attenuated activity)left side of the samples in column 2. Of twelve sugars tested (sor-
bitol, rhamnose, ManNAc, mannose, glucose, glucosamine, GalNAc,
galactose, fructose, xylose, MurNAc, GlcNAc), only GlcNAc was pro-
tective (Fig. S6). In liquid culture the addition of 5 mM GlcNAc re-
versed bacteriostasis (Fig. 2B). During the ten-minute delay prior
to resumption of growth there was a small but consistent decrease
in O.D. 600 nm.
3.3. GccF gene and genomic context analysis
Bacteriocins may be chromosomally or plasmid encoded, and
genes for regulation, maturation, export and immunity are
typically adjacent and arranged in operons [4,17–19]. GccF is chro-
mosomal [8] and encodes 64-amino acid preglycocin F including
an N-terminal 21-amino acid double-glycine leader peptide
(Fig. 3A). Northern blot analysis (Fig. S7) showed that gccF is tran-
scribed from its own promoter, with an estimated 345 nt transcript
size consistent with the in silico prediction of 357 nt starting at
A6426 (Fig. 3A). The gcc gene cluster was predicted to contain eight
genes (Fig. 3B, detailed analysis to be published elsewhere). There
are no intergenic spaces between gccA-E encoding proteins with in-
ferred functions consistent with GccF maturation, export and reg-
ulation (Table S3). GccA-D may form a membrane-bound complex
in which: (1) glycosyltransferase GccA glycosylates Ser18 and/or
Cys43 of preglycocin F, (2) the dedicated C39 (PF03412; cd02418,
E-value: 2e–14)-ABC transporter GccB cleaves the leader peptide
and exports GccF, and (3) exoplasmic membrane-anchored thiore-
doxin domain proteins GccC and/or GccD facilitate disulﬁde bond
formation.
The 422-residue GccA contains a region (Val40-Arg267) with
sequence similarity (E-value: 4e–29) to the b-1,4-glucosyltransfer-
ase domain cd02511 [20] found in enzymes involved in lipooligo-
saccharide biosynthesis, which are a subset of the CAZy database
[21] family 2 glycosyltransferases. There is no signiﬁcant sequence
similarity between residues 268–422 and known proteins, includ-
ing family 41 glycosyltransferases involved in the O-GlcNAc mod-
iﬁcation [22].
Applying the principles used to mine genomic data for bacteri-
ocins [23], the co-location of glycosyltransferase and C39-ABC
transporter genes was used as a criterion to identify Bacillus–
Lactobacillus–Streptococcus group putative glycopeptide bacteriocin
gene clusters. A subset of these is shown in Fig. 3B, and the corre-
sponding bacteriocins in Fig. 3C.
ORFs encoding proteins with cd02511 domains are present
in a few characterised bacteriocin gene clusters, notably thoseptide concentrations indicated were applied to an indicator plate. Bottom row: (i)
M deOGlcNAcGccF. (B) GlcNAc (5 mM) was added to ATCC 8014 cultures at 10, 30, 60 or
indicator agar. (1) GccF treated with 120 mM dithiothreitol (20 C, 3 h); M, marker;
.
Fig. 3. The GccF gene, genomic context analysis, and putative glycopeptide bacteriocins. (A) DNA sequence of gccF. Numbering is from GenBank accession GU552553, and the
translation to preglycocin F is shown. The TAG stop codon of the upstream gccE ORF lies within an imperfect repeat (underlined) with an 18 nt-spacing (AAG-N18-AAG)
characteristic of promoter elements recognised by LytTR response regulators that control transcription of some bacteriocin genes. The imperfect repeat encoding Cys5 and
Cys28 is in bold type. A Rho-independent transcriptional terminator is highlighted (DG = –16.9 kcal/mol). (B) Genomic context of gccF and representative putative
glycopeptide bacteriocin genes. 1, L. plantarum KW30; 2, B. subtilis 168; 3, Enterococcus faecalis HIP11704; 4, E. faecalis TX0104; 5, Streptococcus suis 89-1591. Solid black
arrows are gccF and putative bacteriocin genes (AA sequences of corresponding preglycocins are shown in (C)); vertical lines, glycosyltransferase (GT); diagonal lines, C39-
ABC transporter; grid lines, thioredoxin domain protein; dotted pattern, putative signal transduction/regulation; solid grey, putative immunity; white, unknown. In 4, the
triangle marks the position of a transposase in E. faecalis V583. DNA sequence for the enterocin 96 gene cluster of E. faecalis WHE 96 was not available; the E. faecalis TX0104
gene cluster encoding an identical prebacteriocin (gi:227517439) is shown here. (C) AA sequences of preglycocin F and putative preglycocins, including ASM1 [28], sublancin
[12] and enterocin 96 [24]. Leader peptides (lowercase italics), and known (for GccF and SunA) and hypothetical disulﬁde bonds and glycosylation sites (bold, underlined) are
indicated.
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enterocin 96 [24]. Although a role for peptide glycosyltransferases
in the maturation of bacteriocins from Gram-positive bacteria has
not previously been proposed, the molecular weights of sublancin
and enterocin 96 are greater than predicted, suggesting that they
could be glycopeptides.
3.4. Sublancin 168 is an S-linked glycopeptide bacteriocin
The initial report on sublancin 168 concluded that it contained
lanthionine modiﬁcations [12], presumably introduced by Lanfamily enzymes. However, blastp searches (default parameters)
using LanB, LanM and N-terminal regions of the recently described
LanL proteins [25] as query sequences failed to detect Lan proteins
in the B. subtilis 168 proteome. Given the proximity of sunA to yolJ,
which encodes a cd02511 glycosyltransferase, the alternative
hypothesis that sublancin is a glycopeptide was tested. The
predicted monoisotopic mass of sublancin is 3717.7207 Da,
whereas the mass measured by FT-ICR-MS was 3875.7454 Da,
consistent with two disulﬁde bonds and a covalently attached
hexose (Fig 1A; C162H254N50O51S5, theoretical monoisotopic mass
3875.7422 Da). Subsequent ECD analysis (Table S2B) conﬁrmed
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alkylation with iodoacetamide led to a mass increase equal to
the addition of four carbamidomethyl groups (Fig. S8B and C).
However, the mass of native sublancin was unaffected by incuba-
tion with iodoacetimide (Fig. S8A and D), therefore sublancin, like
GccF, has no free thiols and thus the hexose must be S-linked to
Cys22.
4. Discusssion
Cysteine thiols are precursors for conformationally-constrain-
ing post-translational modiﬁcations such as disulﬁde bonds, cyclic
thioethers and thiazole heterocycles found in a diverse ensemble of
antimicrobial peptides including defensins, lantibiotics and thio-
peptide antibiotics [5,6]. The sulfur to a-carbon bridges of subtilo-
sin A [26] and thuricin CD [27] are further testament to the
versatility of cysteine thiols as substrates for post-translational
modiﬁcation enzymes. Peptide S-glycosylation adds an extra
dimension to cysteine post-translational modiﬁcations, and natu-
ral glycodiversiﬁcation may prove to be an evolutionarily facile
process for generating new and improved bacteriocins.
Recently Hata et al. [28] reported the characterisation of plan-
taricin ASM1, a homologue of GccF. Both bacteriocins are secreted
by L. plantarum strains isolated from fermented corn products, one
sourced from Japan (A-1) and the other from New Zealand (KW30).
Although the post-translational modiﬁcations of ASM1 were not
determined, residues 1-30 are identical to GccF (Fig. 3C), as is the
difference between the theoretical and measured masses, suggest-
ing that ASM1 also contains nested disulﬁdes and two HexNAcs. In
the Edman sequencing of both GccF and ASM1, a single serine gave
no signal. For GccF this was the glycosylated Ser18, whereas for
ASM1 it was reported to be Ser40, highlighting the potential for
strain-speciﬁc glycodiversiﬁcation.
The molecular receptor(s) and mechanism(s) of action of GccF
remain to be elucidated, and may inform the design of new antibi-
otics. The inactivity of deOGlcNAcGccF and reversal of bacteriostasis
by free GlcNAc suggest that the O-linked GlcNAc interacts revers-
ibly with targets in susceptible cells. While the role of the S-linked
HexNAc is enigmatic, it is interesting to consider the evolutionary
and ecological consequences of ‘baiting’ bacteriocins with mono-
saccharides that are components of cell wall polymers and/or sub-
strates for speciﬁc phosphotransferase system (PTS) transporters.
The latter are numerous in L. plantarum [29], and transmembrane
subunits of mannose PTS transporters are known receptors for
class II bacteriocins [30]. Further, the S-glycosidic linkage could
be relatively resistant to cleavage by extracellular and cell enve-
lope glycosidases and transglycosylases, a strategy akin to incorpo-
rating D-amino acids into antimicrobial peptides to minimise
proteolysis [31]. The monosaccharide moieties of GccF and sublan-
cin may also protect against proteolysis, e.g. chymotrypsin cleav-
age at Tyr16 (Table S1). Proteolysis is an established mechanism
of bacteriocin resistance and immunity [32].
Regarding sublancin, the interpretation of results presented by
Paik et al. [12] could have been biased by the then reasonable
hypothesis that this cysteine-rich modiﬁed bacteriocin was a lanti-
biotic, but that hypothesis is no longer tenable. According to Klaen-
hammer’s classiﬁcation scheme [17], both GccF and sublancin 168
are class IV bacteriocins, i.e. those modiﬁed with carbohydrate or
lipid, and the 2005 proposal that class IV bacteriocins be with-
drawn from classiﬁcation schemes for lack of evidence [18] should
therefore be revisited.
The simple genomic context criterion used here can identify
only a fraction of glycopeptide bacteriocins. Given the ubiquity,
diversity and shear number of potential peptide glycosyltransfer-
ase genes in prokaryotes, the phylogenetic distribution of glyco-peptide bacteriocins may prove wider than other classes of
modiﬁed bacteriocins. It will also be interesting to investigate
whether peptide cysteine S-glycosylation is unique to bacteriocins.
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